139 related articles for article (PubMed ID: 12826896)
1. Morphologic and immunophenotypic properties of neoplastic cells in a case of mast cell sarcoma.
Chott A; Guenther P; Huebner A; Selzer E; Parwaresch RM; Horny HP; Valent P
Am J Surg Pathol; 2003 Jul; 27(7):1013-9. PubMed ID: 12826896
[TBL] [Abstract][Full Text] [Related]
2. A case of malignant mastocytosis with circulating mast cell precursors: biologic and phenotypic characterization of the malignant clone.
Baghestanian M; Bankl Hc; Sillaber C; Beil WJ; Radaszkiewicz T; Füreder W; Preiser J; Vesely M; Schernthaner G; Lechner K; Valent P
Leukemia; 1996 Jan; 10(1):159-66. PubMed ID: 8558922
[TBL] [Abstract][Full Text] [Related]
3. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L).
Jordan JH; Walchshofer S; Jurecka W; Mosberger I; Sperr WR; Wolff K; Chott A; Bühring HJ; Lechner K; Horny HP; Valent P
Hum Pathol; 2001 May; 32(5):545-52. PubMed ID: 11381374
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in mastocytosis research. Summary of the Vienna Mastocytosis Meeting 1998.
Valent P; Escribano L; Parwaresch RM; Schemmel V; Schwartz LB; Sotlar K; Sperr WR; Horny HP
Int Arch Allergy Immunol; 1999 Sep; 120(1):1-7. PubMed ID: 10529583
[TBL] [Abstract][Full Text] [Related]
6. Mast cells with bilobed or multilobed nuclei in a nodular lesion of a patient with urticaria pigmentosa.
Hu S; Kuo TT; Hong HS
Am J Dermatopathol; 2002 Dec; 24(6):490-2. PubMed ID: 12454601
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous mastocytosis with atypical mast cells and giant cytoplasmic granules.
Lachapelle J; Moroz B; Nguyen VH
J Cutan Pathol; 2012 Aug; 39(8):773-6. PubMed ID: 22725660
[TBL] [Abstract][Full Text] [Related]
8. Mastocytosis: state of the art.
Horny HP; Sotlar K; Valent P
Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
[TBL] [Abstract][Full Text] [Related]
9. Aleukemic mast cell leukemia with abnormal immunophenotype and c-kit mutation D816V.
Noack F; Sotlar K; Notter M; Thiel E; Valent P; Horny HP
Leuk Lymphoma; 2004 Nov; 45(11):2295-302. PubMed ID: 15512820
[TBL] [Abstract][Full Text] [Related]
10. Mast cell sarcoma of the scalp: the first sign of undisclosed systemic mastocytosis?
Falleti J; Borgia L; Lalinga AV; De Cecio R; Natella V; Patitucci G; Vita G
Pathol Res Pract; 2012 Nov; 208(11):683-6. PubMed ID: 22963840
[TBL] [Abstract][Full Text] [Related]
11. Mast cell tryptase and microphthalmia transcription factor effectively discriminate cutaneous mast cell disease from myeloid leukemia cutis.
Sundram UN; Natkunam Y
J Cutan Pathol; 2007 Apr; 34(4):289-95. PubMed ID: 17381798
[TBL] [Abstract][Full Text] [Related]
12. Mastocytosis.
Brockow K; Metcalfe DD
Chem Immunol Allergy; 2010; 95():110-124. PubMed ID: 20519885
[TBL] [Abstract][Full Text] [Related]
13. Mast cell sarcoma: clinicopathologic and molecular analysis of 10 new cases and review of literature.
Matsumoto NP; Yuan J; Wang J; Shen Q; Chen X; Kim Y; Zuppan CW; Chang CC; Cui W; Chen D; Shi M; Gisriel SD; Chen M; Xu ML; Pan Z
Mod Pathol; 2022 Jul; 35(7):865-874. PubMed ID: 35105959
[TBL] [Abstract][Full Text] [Related]
14. Detection of c-kit point mutation Asp-816 --> Val in microdissected pooled single mast cells and leukemic cells in a patient with systemic mastocytosis and concomitant chronic myelomonocytic leukemia.
Sotlar K; Fridrich C; Mall A; Jaussi R; Bültmann B; Valent P; Horny HP
Leuk Res; 2002 Nov; 26(11):979-84. PubMed ID: 12363464
[TBL] [Abstract][Full Text] [Related]
15. Mastocytosis: immunophenotypical features of the transformed mast cells are unique among hematopoietic cells.
Horny HP; Sotlar K; Valent P
Immunol Allergy Clin North Am; 2014 May; 34(2):315-21. PubMed ID: 24745676
[TBL] [Abstract][Full Text] [Related]
16. Synaptotagmin I expression in mast cells of normal human tissues, systemic mast cell disease, and a human mast cell leukemia cell line.
Kimura N; Shiraishi S; Mizunashi K; Ohtsu H; Kimura I
J Histochem Cytochem; 2001 Mar; 49(3):341-6. PubMed ID: 11181737
[TBL] [Abstract][Full Text] [Related]
17. In vivo differentiation of mast cells from acute myeloid leukemia blasts carrying a novel activating ligand-independent C-kit mutation.
Beghini A; Cairoli R; Morra E; Larizza L
Blood Cells Mol Dis; 1998 Jun; 24(2):262-70. PubMed ID: 9714703
[TBL] [Abstract][Full Text] [Related]
18. CD25 indicates the neoplastic phenotype of mast cells: a novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens.
Sotlar K; Horny HP; Simonitsch I; Krokowski M; Aichberger KJ; Mayerhofer M; Printz D; Fritsch G; Valent P
Am J Surg Pathol; 2004 Oct; 28(10):1319-25. PubMed ID: 15371947
[TBL] [Abstract][Full Text] [Related]
19. Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis.
Sperr WR; Escribano L; Jordan JH; Schernthaner GH; Kundi M; Horny HP; Valent P
Leuk Res; 2001 Jul; 25(7):529-36. PubMed ID: 11377677
[TBL] [Abstract][Full Text] [Related]
20. Mast cell tumors of the gastrointestinal tract in 39 dogs.
Ozaki K; Yamagami T; Nomura K; Narama I
Vet Pathol; 2002 Sep; 39(5):557-64. PubMed ID: 12243465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]